{"slug":"pt-141-blood-pressure-meds","head_index":21,"current":{"title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","updated_at":"2026-07-17T02:41:03.905Z"},"revisions":[{"n":0,"ts":"2026-06-29 08:29:51","title":"PT-141 for Sexual Dysfunction on Blood Pressure Medications","status":"published","bytes":700,"hash":"8237e6aa3c41eecef0d36ccb94d3e0c24d56d5f2cb59c2562748f3054facabf5"},{"n":1,"ts":"2026-06-29T09:22:09.299Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1858,"hash":"fef40f79bb6ef3f28c5b7040e7a07ebb0408985551d83d8ee896eb30e7eaa030"},{"n":2,"ts":"2026-06-29T11:21:07.028Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1858,"hash":"84c796c2751cf5ea008bfecef3bd17ad6d6421c1ac6eb43e612debef375290aa"},{"n":3,"ts":"2026-06-29 12:00:15","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"bfd684f6d5c40701d43bf71af928b13cf9a65c26d4c0e63996b351c05546c04c"},{"n":4,"ts":"2026-06-29T12:49:22.254Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"30ab4bb0641c9bc717f34b8c38160c013a8fd4f41d73bd11ace3049b5b06333a"},{"n":5,"ts":"2026-06-29T12:49:22.830Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"4635cea8f40e92605b27cf5cc11d0eb0f578ca67366f0bbbd073fc5dd6bbc1d3"},{"n":6,"ts":"2026-06-29T12:49:22.907Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"58b65e20e6798117fb6ea767db1d9937e3b22b115af0fc477302aad23d67280e"},{"n":7,"ts":"2026-06-29T12:49:22.972Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"d748cb340df6bbfdcbfe4f203e0ca949a9fb93617b3eddb335d637eddf7cae54"},{"n":8,"ts":"2026-06-29T12:49:23.028Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"de08ceb75f18ea2ac7ea75de964e47a12ef7225bfe6be912ce8d5de7635d3a6e"},{"n":9,"ts":"2026-06-29T12:49:23.169Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"690daedec6093070079a375cea547beedb591e89af7024d38bb6e3ad0946bf87"},{"n":10,"ts":"2026-06-29T12:49:23.841Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"dbf0bb244dacd60f18b09e75d9cd3e055f9e1bf81b1fa1f93b04b632f493b4a4"},{"n":11,"ts":"2026-06-29T13:23:06.719Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"2cafbb30a0e7ddfa1387e8ba6338140651528da07ce94d4ccc6901ad3f479f33"},{"n":12,"ts":"2026-06-29T13:23:07.913Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"ab20aa7b3064390641b6a1e64e8eea66a45cf26aad935d29624f44b7c24196e9"},{"n":13,"ts":"2026-06-29T14:50:09.036Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"ef2143a8d9c7c59d23da54b322afb69029c5464381a3677f246055d8f4d5dd86"},{"n":14,"ts":"2026-06-29T16:48:06.800Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"219438abe9d24f03a8e52a13d672b8a9f22cbf20cdc436d3f87a9a8c7467f0c3"},{"n":15,"ts":"2026-06-29T18:34:27.270Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"e1a67806aed7ae25a5710ff0bb469579ab88d24749270d75a363e9e53e1d9976"},{"n":16,"ts":"2026-06-29T18:35:00.277Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"7cd4b8462ec7c109fb1c022176112955294e28161b27d44f82d2bd82b47d90bd"},{"n":17,"ts":"2026-06-29T18:35:22.270Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"5f89d53315fb8cb24c5f8704efc7d6775881b2343757b052537a2a2c1bc9c45a"},{"n":18,"ts":"2026-06-29T18:36:47.791Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"0a226e61139a8ff4489e3b48d2b00aced71b7aee37dd2ea922793b8eb845f0a7"},{"n":19,"ts":"2026-06-29T20:05:05.429Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"ff7894bf826ae23e3af2f80406fa3f95340f865512a677a91e899b7520e393f5"},{"n":20,"ts":"2026-06-29T21:16:09.627Z","title":"PT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood Pressure Medications: Evidence Summary","status":"published","bytes":1911,"hash":"3de2d713c624f0ca21542c98a32e7f957a8ec9636c274408ea128672ba1a9dff"}]}